Revenue (Tables)

3 Months Ended

Jul. 26, 2019

The table below illustrates net sales by market geography for each segment for the three months ended July 26, 2019 and July 27, 2018:



	U.S.⁽¹⁾⁽⁴⁾				Non-U.S. Developed Markets⁽²⁾⁽⁴⁾				Emerging Markets⁽³⁾⁽⁴⁾
	Three months ended				Three months ended				Three months ended
(in millions)	July 26, 2019		July 27, 2018		July 26, 2019		July 27, 2018		July 26, 2019		July 27, 2018
Cardiac and Vascular Group	$	1,361	$	1,389	$	930	$	947	$	499	$	475
Minimally Invasive Therapies Group	913		857		791		828		396		367
Restorative Therapies Group	1,338		1,294		426		428		248		227
Diabetes Group	306		324		231		203		55		45
Total	$	3,918	$	3,864	$	2,377	$	2,406	$	1,198	$	1,114


(1)	U.S. includes the United States and U.S. territories.


(2)	Non-U.S. developed markets include Japan, Australia, New Zealand, Korea, Canada, and the countries within Western Europe.


(3)	Emerging markets include the countries of the Middle East, Africa, Latin America, Eastern Europe, and the countries of Asia that are not included in the non-U.S. developed markets, as defined above.

(4)

Revenue amounts have intentionally been rounded to the nearest million and, therefore, may not sum.

The table below illustrates net sales by segment and division for the three months ended July 26, 2019 and July 27, 2018:



	Three months ended⁽¹⁾
(in millions)	July 26, 2019		July 27, 2018
Cardiac Rhythm & Heart Failure	$	1,382	$	1,426
Coronary & Structural Heart	941		917
Aortic, Peripheral, & Venous	467		468
Cardiac and Vascular Group	2,790		2,811
Surgical Innovations	1,417		1,397
Respiratory, Gastrointestinal, & Renal	683		655
Minimally Invasive Therapies Group	2,100		2,052
Brain Therapies	740		674
Spine	658		652
Specialty Therapies	322		309
Pain Therapies	292		314
Restorative Therapies Group	2,012		1,949
Diabetes Group	592		572
Total	$	7,493	$	7,384

(1) Revenue amounts have intentionally been rounded to the nearest million and, therefore, may not sum.